RAB38 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.275200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.166800E-01
Normal-vs-Stage2
1.938760E-01
Normal-vs-Stage3
1.896170E-01
Normal-vs-Stage4
9.446300E-02
Stage1-vs-Stage2
3.926400E-01
Stage1-vs-Stage3
5.136000E-01
Stage1-vs-Stage4
1.922430E-01
Stage2-vs-Stage3
8.393400E-01
Stage2-vs-Stage4
7.067000E-01
Stage3-vs-Stage4
5.881400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.602200E-01
Normal-vs-AfricanAmerican
8.774200E-02
Normal-vs-Asian
6.675600E-02
Caucasian-vs-AfricanAmerican
7.885400E-01
Caucasian-vs-Asian
1.588810E-01
AfricanAmerican-vs-Asian
4.442600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.179000E-01
Normal-vs-Female
2.403400E-01
Male-vs-Female
3.548800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.344200E-01
Normal-vs-Age(41-60Yrs)
1.697380E-01
Normal-vs-Age(61-80Yrs)
2.393200E-01
Normal-vs-Age(81-100Yrs)
1.505600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.758400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.183800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.752800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.783500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.655150E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.166000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.874400E-01
Normal-vs-Daily Drinker
3.117000E-01
Normal-vs-Weekly Drinker
8.551900E-02
Normal-vs-Occasional Drinker
1.215200E-01
Normal-vs-Social Drinker
1.284430E-01
Non Drinker-vs-Daily Drinker
5.361800E-01
Non Drinker-vs-Weekly Drinker
6.247400E-01
Non Drinker-vs-Occasional Drinker
4.319800E-02
Non Drinker-vs-Social Drinker
6.293000E-01
Daily Drinker-vs-Weekly Drinker
2.399400E-01
Daily Drinker-vs-Occasional Drinker
1.736340E-02
Daily Drinker-vs-Social Drinker
4.494400E-01
Weekly Drinker-vs-Occasional Drinker
8.920300E-02
Weekly Drinker-vs-Social Drinker
8.146800E-01
Occasional Drinker-vs-Social Drinker
3.569200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.818200E-01
Normal-vs-Grade 2
1.782570E-01
Normal-vs-Grade 3
3.054200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.388600E-04
Grade 1-vs-Grade 3
1.078520E-03
Grade 1-vs-Grade 4
4.818200E-01
Grade 2-vs-Grade 3
1.275380E-01
Grade 2-vs-Grade 4
1.782570E-01
Grade 3-vs-Grade 4
3.054200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.739200E-01
Normal-vs-NonDiabetic
2.492200E-01
Diabetic-vs-NonDiabetic
7.178000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.079800E-02
Normal-vs-NoPancreatitis
2.262400E-01
Pancreatitis-vs-NoPancreatitis
3.870600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.529600E-01
Normal-vs-N1
1.360230E-01
N0-vs-N1
7.099200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.403300E-04
Normal-vs-TP53-NonMutant
2.439600E-01
TP53-Mutant-vs-TP53-NonMutant
9.770500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
